Delivery Order SPE2DR25D3301-SPE2DR26F22WS

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 20, 2026, with a ceiling value of $8,184.22 for CABENUVA ER 600 mg-900 mg suspension 6 ml pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 13, 2026. The order carries firm fixed pricing and was issued under no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for CABENUVA ER 600 mg–900 mg suspension (6 mL), with a ceiling value of $12,276.33.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 13, 2026, with a ceiling value of $16,368.44 for CABENUVA ER 600 MG-900 MG suspension (6 mL).</p> <p>Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with an ultimate completion date of March 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, with a ceiling value of $16,368.44 for CABENUVA ER 600 MG-900 MG suspension 6 mL pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 2, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $32,736.88 delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for CABENUVA ER 600 MG-900 MG suspension 6 mL pharmaceutical supply. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 13, 2026. The order carries firm fixed pricing and was not...

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL units, with a contract ceiling value of $4,022.43 and an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,184.22 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...

The Defense Logistics Agency awarded a $40,921.10 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities. The contract, which is not set-aside, has an ultimate completion date of January 30, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery...

The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,562.45 on December 11, 2025, for CABENUVA ER 600 MG-900 MG suspension (6 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude by January 5, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical...